Henry Schein | HSIC - Sales Revenues

Stock Price
73.89
Daily Change
-2.23 -2.93%
Monthly
1.64%
Yearly
13.73%
Q2 Forecast
75.88

Henry Schein reported $3.4B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Agilent USD 1.8B 63M Dec/2025
Align Technology USD 1.05B 54.3M Dec/2025
Bruker USD 977.2M 116.7M Dec/2025
Cardinal Health USD 65.63B 1.63B Dec/2025
Charles River Laboratories USD 994.2M 5.8M Dec/2025
Cigna USD 72.47B 2.77B Dec/2025
Concord Medical Services Hldg CNY 200.61M 83.9M Jun/2025
Cooper Companies USD 1.02B 41.1M Dec/2025
CVS Health USD 105.7B 2.8B Dec/2025
Danaher USD 5.95B 890M Mar/2026
Dentsply International USD 961M 57M Dec/2025
Encompass Health USD 1.54B 60M Dec/2025
Henry Schein USD 3.4B 60M Dec/2025
Idexx Laboratories USD 1.09B 10M Dec/2025
IQVIA Holdings USD 4.36B 260M Dec/2025
Laboratory Of America USD 3.52B 40M Dec/2025
McKesson USD 106.16B 3.01B Dec/2025
Mettler Toledo International USD 1.13B 100M Dec/2025
Owens Minor USD 708.97M 11.71M Dec/2025
Quest Diagnostics USD 2.9B 90M Mar/2026
Revvity USD 772.06M 73.06M Dec/2025
Stryker USD 7.2B 1.14B Dec/2025
Tenet Healthcare USD 5.53B 240M Dec/2025
Thermo Fisher Scientific USD 11.01B 1.2B Mar/2026
Universal Health Services USD 4.49B 0 Mar/2026
Veradigm USD 142.52M 9.38M Dec/2022
Waters USD 932M 132M Dec/2025
Zimmer Biomet Holdings USD 2.09B 150M Mar/2026
Zoetis USD 2.4B 0 Dec/2025